Salmeterol
Links shared publicly online about this topic
Tiotropium Outperforms Salmeterol in Moderate COPD - Physician's First Watch
firstwatch.jwatch.org — “The anticholinergic drug tiotropium is more effective at forestalling exacerbations in chronic obstructive pulmonary disease than the beta-2 agonist salmeterol, according to a New England Journal of Medicine study. International researchers (including employees of tiotropium's . . . LINK(S):” View full resource at firstwatch.jwatch.org
Most Recently Shared on March 25, 2011 at 1:17 am By:
Tiotropium Outperforms Salmeterol in Moderate COPD - http://icio.us/PNudqL
Tiotropium superior to salmeterol in preventing exacerbations in COPD - - Drug Topics
drugtopics.modernmedicine.com — “The anticholinergic drug tiotropium is more effective than the ?2-agonist salmeterol in preventing exacerbations in patients with moderate-to-very-severe chronic obstructive pulmonary disease, according to a multi-center European study published in the New England Journal of Medicine.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on April 9, 2011 at 2:24 am By:
Tiotropium superior to salmeterol in preventing exacerbations in COPD: The anticholinergic drug tiotropium is mo... http://bit.ly/e7E9FM
Tiotropium vs. Salmeterol for COPD Exacerbations - QualityPoint Technologies
qualitypointtech.net — “Both inhaled long-acting beta-agonists and inhaled anticholinergic agents are first-line treatments for patients with moderate-to-severe chronic obstructive pulmonary disease. Which is better? Journal Watch” View full resource at qualitypointtech.net
Most Recently Shared on April 13, 2011 at 10:35 am By:
Tiotropium vs. Salmeterol for COPD Exacerbations: Both inhaled long-acting beta-agonists and inhaled anticholinerg... http://bit.ly/ffaGpD
FLUTICASONE/SALMETEROL COMBINATION CONFERS BENEFITS IN SMOKING ASTHMATICS
chestjournal.chestpubs.org — “Clearie, Karine L.; McKinlay, Lorna; Williamson, Peter A.; Lipworth, Brian J.” View full resource at chestjournal.chestpubs.org
Most Recently Shared on June 7, 2011 at 11:30 am By:
Fluticasone/salmeterol confers improvements in airway hyper-responsiveness and caliber in smoking asthmatics http://bit.ly/lQNOsB
Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol-fluticasone
ncbi.nlm.nih.gov — “Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol-fluticasone” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on September 24, 2010 at 12:12 pm By:
Onset of action of indacaterol in patients with COPD http://tiny.cc/osdg2
Novartis lung drug better than salmeterol in COPD http://dlvr.it/5Z9cg
reuters.com — “Novartis lung drug better than salmeterol in COPD http://dlvr.it/5Z9cg” View full resource at reuters.com
Most Recently Shared on September 20, 2010 at 6:10 am By:
Novartis lung drug better than salmeterol in COPD http://dlvr.it/5Z9cg
FDA Alert: Advair Diskus (fluticasone propionate and salmeterol inhalation powder): Stolen Product Warning
drugs.com — “FDA Alert: Advair Diskus (fluticasone propionate and salmeterol inhalation powder): Stolen Product Warning” View full resource at drugs.com
Most Recently Shared on July 16, 2010 at 8:14 pm By:
FDA Alert - Advair Diskus Stolen Product Warning - http://bit.ly/aztpdG
Family Med Medical News about Pulmonary Disease, Chronic Obstructive; tiotropium, salmeterol
mdlinx.com — “Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms” View full resource at mdlinx.com
Most Recently Shared on June 5, 2010 at 5:47 am By:
Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms: Respiratory M... http://bit.ly/caRPYZ #GM #mdlinx
Inhaler Wars: Tiotropium versus Salmeterol for Chronic Obstructive Pulmonary Disease | Now@NEJM
blogs.nejm.org — “COPD sufferers know the symptoms all too well: the phlegmy cough, gasping wheezy breaths, and chest tightness that signal an exacerbation. Guidelines recommend” View full resource at blogs.nejm.org
Most Recently Shared on March 23, 2011 at 9:01 pm By:
NEJM: Inhaler Wars: Tiotropium versus Salmeterol for Chronic Obstructive Pulmonary Disease http://bit.ly/h29bUN
Inhaler Wars: Tiotropium versus Salmeterol for Chronic Obstructive Pulmonary Disease | Now@NEJM
blogs.nejm.org — “COPD sufferers know the symptoms all too well: the phlegmy cough, gasping wheezy breaths, and chest tightness that signal an exacerbation. Guidelines recommend” View full resource at blogs.nejm.org
Most Recently Shared on March 23, 2011 at 11:02 pm By:
@NEJM Inhaler Wars: Tiotropium versus Salmeterol for Chronic Obstructive Pulmonary Disease http://bit.ly/enibSt #medical #journal
Novartis lung drug better than salmeterol in COPD - QualityPoint Technologies
qualitypointtech.net — “ZURICH (Reuters) - Novartis' lung drug Onbrez Breezhaler allows patients with a deadly lung disease to breathe more easily than a current mainstay treatment, adding to positive sentiment surrounding the Swiss drugmaker. (Source: Reuters: Health)” View full resource at qualitypointtech.net
Most Recently Shared on September 20, 2010 at 7:49 am By:
Novartis lung drug better than salmeterol in COPD: ZURICH (Reuters) - Novartis' lung drug Onbrez Breezhaler allow... http://bit.ly/9ThYc9
Comparison of the Effect of Low-Dose Ciclesonide and Fixed-Dose Fluticasone Propionate and Salmeterol Combination on Long-term Asthma Control --" CHEST
chestjournal.chestpubs.org — “Postma, Dirkje S.; O--™Byrne, Paul M.; Pedersen, Sren” View full resource at chestjournal.chestpubs.org
Most Recently Shared on February 1, 2011 at 4:44 pm By:
Effect of Low-Dose Ciclesonide and Fixed-Dose Fluticasone and Salmeterol Combination on Long-term Asthma Control http://t.co/X8hCb1h
Budesonide/Formoterol vs. Salmeterol/Fluticasone in COPD - QualityPoint Technologies
qualitypointtech.net — “This analysis looks at two widely-used combination inhalers for treatment of COPD. Is one product more likely to cause pneumonia than the other? International Journal of Clinical Practice” View full resource at qualitypointtech.net
Most Recently Shared on July 20, 2011 at 3:45 pm By:
Budesonide/Formoterol vs. Salmeterol/Fluticasone in COPD: This analysis looks at two widely-used combination inhal... http://bit.ly/nyVDIu
{beta}2-Receptor Polymorphisms in Patients Receiving Salmeterol with or without Fluticasone Propionate -- Bleecker et al. 181 (7): 676 -- American Journal of Respiratory and Critical Care Medicine
ajrccm.atsjournals.org — “{beta}2-Receptor Polymorphisms in Patients Receiving Salmeterol with or without Fluticasone Propionate -- Bleecker et al. 181 (7): 676 -- American Journal of Respiratory and Critical Care Medicine” View full resource at ajrccm.atsjournals.org
Most Recently Shared on March 25, 2010 at 12:05 am By:
No evidence of a pharmacogenetic effect of ?-receptor variation on salmeterol response.http://is.gd/aXr7K
ScienceDirect - Journal of Allergy and Clinical Immunology : Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma
sciencedirect.com — “ScienceDirect - Journal of Allergy and Clinical Immunology : Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma” View full resource at sciencedirect.com
Most Recently Shared on August 4, 2011 at 11:31 am By:
#Tiotropium is noninferior to #salmeterol in maintaining improved lung function in B16-Arg/Arg patients with #asthma - http://ow.ly/5UWU2
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Lionel Lim
Board Certified MD (internal medicine, geriatrics, general preventive medicine & public health, hospice and palliative medicine) involved in medical education.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
Advertisement

